zithromax has been researched along with Anemia--Hemolytic--Autoimmune* in 3 studies
1 review(s) available for zithromax and Anemia--Hemolytic--Autoimmune
| Article | Year |
|---|---|
Mycoplasma pneumoniae associated with severe autoimmune hemolytic anemia: case report and literature review.
We report a case of severe hemolytic anemia following Mycoplasma pneumoniae infection in a 29-year-old male patient who was treated with azithromycin. Direct Coombs' test was strongly positive and the cold agglutinin titer was high, with anti-I specificity. Antimycoplasma antibody titer by complement fixation was high 1:10,240. The patient was discharged after 12 days of hospitalization in good health. He remains clinically well with no recurrence of jaundice. Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Azithromycin; Humans; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Severity of Illness Index | 2009 |
2 other study(ies) available for zithromax and Anemia--Hemolytic--Autoimmune
| Article | Year |
|---|---|
Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia.
Topics: Anemia, Hemolytic, Autoimmune; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tomography, X-Ray Computed | 2020 |
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report.
In December 2019, a new coronavirus (named severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) spread from China, causing a pandemic in a very short time. The main clinical presentation of SARS-CoV-2 infection (COVID-19, coronavirus disease-2019) is pneumonia, but several cardiovascular complications may also occur (e.g., acute coronary syndromes, pulmonary embolism, stroke, arrhythmias, heart failure and cardiogenic shock). Direct or indirect mechanisms induced by SARS-CoV-2 could be implicated in the pathogenesis of these events.. We report herein the third case of COVID-19 autoimmune haemolytic anaemia (AIHA) reported so far, which occurredwithout any other possible explanations in a Caucasian patient. The patient also suffered from ST-elevation myocardial injury.. Both complications occurred quite late after COVID-19 diagnosis and were probably precipitated by systemic inflammation, as indicated by a significant delayed increase in inflammatory markers, including interleukin-6 (IL-6). Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Asymptomatic Infections; Azithromycin; C-Reactive Protein; Coombs Test; COVID-19; COVID-19 Drug Treatment; Electrocardiography; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin-6; Platelet Aggregation Inhibitors; Prednisolone; SARS-CoV-2; ST Elevation Myocardial Infarction | 2020 |